Many patients hear that they need a certain BMI to qualify for GLP-1 weight loss treatment, but they are not always sure how BMI is actually calculated
It supports biosynthesis of acetylcholine, the most abundant neurotransmitter in the body, regulating activities of vital organs and blood vessels and communication between nerves and muscles
Both classes lower blood glucose, promote weight loss, and reduce cardiovascular risk, but SGLT2 inhibitors have stronger evidence for kidney and heart failure protection and are generally preferred in those conditions
Neurological manifestations of long-COVID syndrome: A narrative review
The rapid rise of GLP-1 weight-loss drugs is beginning to alter consumer behaviour in the UK, with significant implications for the food, drink and hospitality sectors
This results in firmer, smoother skin with minimal discomfort